51. Safety and outcomes of routine endovascular thrombectomy in large artery occlusion recorded in the SITS Register: An observational study
- Author
-
Niaz Ahmed, M Brozman, Jyrki Ollikainen, Ana Paiva Nunes, Antonio Dávalos, Lubomír Jurák, Miroslava Nevsimalova, Andrea Zini, Paolo Frigio Nichelli, Anna Peeters, Kennedy R. Lees, Roman Herzig, Michael V. Mazya, E Hurtikova, Robert Mikulik, Staffan Holmin, G Tsivgoulis, Tiago Moreira, Irene Escudero-Martínez, Laura Dorado, Guido Bigliardi, R Cavallo, R Tassi, Danilo Toni, Daniel Strbian, Jose Antonio Egido, Karolinska Institute, Stockholm County Council, Swedish Heart-Lung Foundation, Order of Saint John in Sweden, Friends of Karolinska Institute, Boehringer Ingelheim Fonds, European Commission, Biogen, Stryker, Covidien, Phenox, Ragnar Söderberg Foundation, Torsten Söderberg Foundation, The Erling-Persson Family Foundation, VINNOVA (Sweden), Junta de Andalucía, Ministry of Health of the Czech Republic, Charles University (Czech Republic), Neurologian yksikkö, HUS Neurocenter, Clinicum, UCL - SSS/IONS - Institute of NeuroScience, UCL - SSS/IONS/NEUR - Clinical Neuroscience, UCL - (SLuc) Service de neurologie, Tampere University, and Department of Neurosciences and Rehabilitation
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Real-world registry ,medicine.medical_treatment ,HSJ UCV ,030204 cardiovascular system & hematology ,real-world registry ,stroke ,thrombectomy ,3121 Internal medicine ,3124 Neurology and psychiatry ,law.invention ,Brain Ischemia ,03 medical and health sciences ,0302 clinical medicine ,Randomized controlled trial ,ALTEPLASE ,law ,Modified Rankin Scale ,medicine.artery ,Internal Medicine ,medicine ,Anterior cerebral artery ,Humans ,ACUTE ISCHEMIC-STROKE ,Stroke ,Randomized Controlled Trials as Topic ,Retrospective Studies ,Thrombectomy ,business.industry ,real‐ ,MECHANICAL THROMBECTOMY ,Arteries ,Endovascular Procedures ,Intracranial Hemorrhages ,Treatment Outcome ,Thrombolysis ,3126 Surgery, anesthesiology, intensive care, radiology ,medicine.disease ,3. Good health ,Surgery ,030104 developmental biology ,Middle cerebral artery ,UPDATE ,Observational study ,Internal carotid artery ,business ,world registry - Abstract
[Background and objective] We aimed to evaluate the safety and outcomes of thrombectomy in anterior circulation acute ischaemic stroke recorded in the SITS–International Stroke Thrombectomy Register (SITS-ISTR) and compare them with pooled randomized controlled trials (RCTs) and two national registry studies., [Methods] We identified centres recording ≥10 consecutive patients in the SITS-ISTR with at least 70% of available modified Rankin Scale (mRS) at 3 months during 2014–2019. We defined large artery occlusion as intracranial internal carotid artery, first and second segment of middle cerebral artery and first segment of anterior cerebral artery. Outcome measures were functional independence (mRS score 0-2) and death at 3 months and symptomatic intracranial haemorrhage (SICH) per modified SITS-MOST., [Results] Results are presented in the following order: SITS-ISTR, RCTs, MR CLEAN Registry and German Stroke Registry (GSR). Median age was 73, 68, 71 and 75 years; baseline NIHSS score was 16, 17, 16 and 15; prior intravenous thrombolysis was 62%, 83%, 78% and 56%; onset to reperfusion time was 289, 285, 267 and 249 min; successful recanalization (mTICI score 2b or 3) was 86%, 71%, 59% and 83%; functional independence at 3 months was 45.5% (95% CI: 44–47), 46.0% (42–50), 38% (35–41) and 37% (35–41), respectively; death was 19.2% (19–21), 15.3% (12.7–18.4), 29.2% (27–32) and 28.6% (27–31); and SICH was 3.6% (3–4), 4.4% (3.0–6.4), 5.8% (4.7–7.1) and not available., [Conclusion] Thrombectomy in routine clinical use registered in the SITS-ISTR showed safety and outcomes comparable to RCTs, and better functional outcomes and lower mortality than previous national registry studies., SITS (Safe Implementation of Treatment in Stroke) is financed directly and indirectly by grants from Karolinska Institutet, Stockholm County Council, the Swedish Heart-Lung Foundation, the Swedish Order of St. John, Friends of Karolinska Institutet and private donors, as well as from an unrestricted sponsorship from Boehringer Ingelheim. SITS has previously received grants from the European Union Framework 7, the European Union Public Health Authority, Ferrer International and EVER Pharma. SITS is currently conducting studies supported by Boehringer Ingelheim and Biogen, as well as in collaboration with Karolinska Institutet, supported by Stryker, Covidien and Phenox. N Ahmed is supported by grants provided by the Stockholm County Council and the Swedish Heart-Lung Foundation. S Holmin is supported by grants provided by the Söderberg Foundations, the Stockholm County Council, the Erling Persson Foundation, VINNOVA and HMT. Irene Escudero-Martínez has received a grant from ‘Fundación Progreso y Salud, Junta de Andalucía’ (grant EF-0437-2018). RM has been supported by the project no. LQ1605 from the National Program of Sustainability II (MEYS CR). RH has been supported by the grants no. DRO–UHHK 00179906 from the Ministry of Health of the Czech Republic and no. PROGRES Q40 from Charles University, Czech Republic.
- Published
- 2021